Understanding the Clinical Efficacy of Immune Stimulating Conjugates

Time: 4:45 pm
day: day 1- pm

Details:

  • Examining Upifitamab Rilsodotin clinical data
  • Showcasing results from the UP-NEXT, Phase III monotherapy trial in platinum sensitive recurrent ovarian cancer
  • Exploring results from XMT-1592 and XMT-1660 dose escalation trial results

Speakers: